BTMD
BTMD
NASDAQ · Pharmaceuticals

Biote Corp -A

$1.60
+0.07 (+4.58%)
As of Mar 23, 10:09 PM ET ·
Financial Highlights (FY 2026)
Revenue
196.53M
Net Income
27.65M
Gross Margin
71.5%
Profit Margin
14.1%
Rev Growth
+5.2%
D/E Ratio
9.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.5% 71.5% 32.3% 32.3%
Operating Margin 18.5% 16.6% 17.4% 19.3%
Profit Margin 14.1% 13.4% 14.6% 19.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 196.53M 186.78M 22.38M 21.94M
Gross Profit 140.44M 133.48M 7.24M 7.09M
Operating Income 36.36M 31.10M 3.89M 4.25M
Net Income 27.65M 23.65M 3.27M 4.37M
Gross Margin 71.5% 71.5% 32.3% 32.3%
Operating Margin 18.5% 16.6% 17.4% 19.3%
Profit Margin 14.1% 13.4% 14.6% 19.9%
Rev Growth +5.2% +5.2% -5.1% +24.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 24.30M 24.30M 11.22M 12.91M
Total Equity 2.69M 2.69M 63.17M 61.05M
D/E Ratio 9.02 9.02 0.18 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 53.39M 48.20M 5.70M 5.36M
Free Cash Flow 2.62M 2.18M